EVERSANA Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • EVERSANA's estimated annual revenue is currently $28.9M per year.(i)
  • EVERSANA's estimated revenue per employee is $201,000

Employee Data

  • EVERSANA has 144 Employees.(i)
  • EVERSANA grew their employee count by -9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.6M3815%N/AN/A
#2
$32.4M1615%N/AN/A
#3
$30.2M1509%N/AN/A
#4
$82.4M410N/AN/AN/A
#5
$5.4M27-7%N/AN/A
#6
$11.7M58-5%N/AN/A
#7
$5.8M290%N/AN/A
#8
$8M403%N/AN/A
#9
$0.8M40%N/AN/A
#10
$10.1M500%N/AN/A
Add Company

EVERSANA™ combines the leading global life science services into an integrated, independent and intelligent commercialization platform. With services rooted in the patient experience and spanning global pricing, market access, marketing, patient support, channel distribution, and consulting, we create value for patients, prescribers and payers at all stages of the product lifecycle. To learn more about our work to help clients – ranging from innovative start-ups to established pharmaceutical companies - advance life science services for a healthier world, visit eversana.com

keywords:N/A

N/A

Total Funding

144

Number of Employees

$28.9M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EVERSANA News

2022-04-17 - Eversana, UpScriptHealth ally on digital patient platform -

UpScriptHealth has joined forces with Eversana on a digital platform that aims to improve patient access to therapies, and the experience...

2022-04-13 - EVERSANA and UpScriptHealth Announce Integrated, Direct ...

EVERSANA and UpScriptHealth Announce Integrated, Direct-to-Patient Platform, Transforming the Patient Journey to Accelerate Therapy Access,...

2022-04-13 - Colliers sells headquarters building in Milwaukee's Third ...

Chicago St. in Milwaukee's historic Third Ward neighborhood. The 42,000-square-foot Class-A headquarters is currently occupied by tenant Eversana, a life-...

2021-08-17 - Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment

CAMBRIDGE, Mass., Aug. 17, 2021 /PRNewswire/ -- Shorla Pharma ('Shorla'), a specialty pharmaceutical company and EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced a partnership to support the launch and commercialization of Shor ...

2021-07-26 - EVERSANA™ expands global commercialization solutions with acquisition of Accelera Canada and its partner companies

CHICAGO, July 26, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced the acquisition of Accelera Canada and its partner companies Patient Access Solutions, Podium Strategic Partners, Inc., and Advocacy Soluti ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M14435%N/A
#2
$51.6M1468%N/A
#3
$43.4M14623%N/A
#4
$15M14613%N/A
#5
$16.2M1476%N/A